James Cleary

6.5k total citations · 1 hit paper
85 papers, 5.4k citations indexed

About

James Cleary is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, James Cleary has authored 85 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cellular and Molecular Neuroscience, 26 papers in Physiology and 24 papers in Molecular Biology. Recurrent topics in James Cleary's work include Alzheimer's disease research and treatments (20 papers), Neuropeptides and Animal Physiology (16 papers) and Receptor Mechanisms and Signaling (15 papers). James Cleary is often cited by papers focused on Alzheimer's disease research and treatments (20 papers), Neuropeptides and Animal Physiology (16 papers) and Receptor Mechanisms and Signaling (15 papers). James Cleary collaborates with scholars based in United States, United Kingdom and Ireland. James Cleary's co-authors include Karen H. Ashe, Dominic M. Walsh, Dennis J. Selkoe, J. Hofmeister, Michael A. Kuskowski, Ganesh M. Shankar, Eugene O‘Hare, Betty Diamond, Dariush Moussai and A. Selma Dagtas and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Neuroscience.

In The Last Decade

James Cleary

85 papers receiving 5.3k citations

Hit Papers

Natural oligomers of the amyloid-β protein specifically d... 2004 2026 2011 2018 2004 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Cleary United States 32 2.9k 1.6k 1.5k 805 698 85 5.4k
Takeshi Tabira Japan 52 3.5k 1.2× 3.3k 2.0× 1.7k 1.1× 925 1.1× 1.4k 2.1× 257 9.9k
Verónica Galván United States 45 2.9k 1.0× 2.6k 1.6× 1.1k 0.8× 745 0.9× 1.1k 1.6× 93 6.7k
David Blum France 51 2.5k 0.9× 3.0k 1.9× 2.7k 1.8× 774 1.0× 1.6k 2.3× 194 8.6k
Kimberly Scearce‐Levie United States 35 3.0k 1.0× 2.4k 1.5× 2.1k 1.5× 974 1.2× 896 1.3× 55 5.8k
James A. Clemens United States 49 1.2k 0.4× 2.2k 1.4× 1.9k 1.3× 504 0.6× 850 1.2× 158 6.9k
Atsumi Nitta Japan 46 1.5k 0.5× 2.2k 1.3× 2.8k 1.9× 927 1.2× 956 1.4× 181 6.4k
Fang Cai China 32 1.7k 0.6× 1.8k 1.1× 905 0.6× 427 0.5× 555 0.8× 91 4.2k
Xia Liu China 51 2.3k 0.8× 4.1k 2.5× 2.1k 1.4× 652 0.8× 963 1.4× 195 8.8k
Louis B. Hersh United States 55 3.3k 1.2× 4.9k 3.0× 4.1k 2.8× 1.4k 1.7× 966 1.4× 223 10.5k
Roger N. Rosenberg United States 41 1.7k 0.6× 2.3k 1.4× 1.7k 1.2× 484 0.6× 728 1.0× 192 5.9k

Countries citing papers authored by James Cleary

Since Specialization
Citations

This map shows the geographic impact of James Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Cleary more than expected).

Fields of papers citing papers by James Cleary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Cleary. The network helps show where James Cleary may publish in the future.

Co-authorship network of co-authors of James Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of James Cleary. A scholar is included among the top collaborators of James Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Cleary. James Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbert, Jessica R., Arnaud F. Klein, Amos Gutnick, et al.. (2024). 440P Nonclinical data for PGN-EDODM1 demonstrated nuclear delivery, mechanistic and meaningful activity for the potential treatment of DM1. Neuromuscular Disorders. 43. 104441.515–104441.515. 1 indexed citations
2.
O’Nuallain, Brian, Igor Klyubin, Jessica M. Mc Donald, et al.. (2011). A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ. Journal of Neurochemistry. 119(1). 189–201. 26 indexed citations
3.
Kotilinek, Linda, Marcus A. Westerman, Qinwen Wang, et al.. (2008). Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity. Brain. 131(3). 651–664. 187 indexed citations
4.
Poling, Alan, J Panos, Eun‐Mee Kim, et al.. (2008). Oligomers of the amyloid-β protein disrupt working memory: Confirmation with two behavioral procedures. Behavioural Brain Research. 193(2). 230–234. 64 indexed citations
5.
Cleary, James, Dominic M. Walsh, J. Hofmeister, et al.. (2004). Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neuroscience. 8(1). 79–84. 1417 indexed citations breakdown →
6.
Grimaldi, Christine, James Cleary, A. Selma Dagtas, Dariush Moussai, & Betty Diamond. (2002). Estrogen alters thresholds for B cell apoptosis and activation. Journal of Clinical Investigation. 109(12). 1625–1633. 340 indexed citations
7.
Richardson, R.L., et al.. (2002). Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Aβ(1–42) injections in the rat. Brain Research. 954(1). 1–10. 57 indexed citations
8.
O‘Hare, Eugene, et al.. (2000). Varied duration of congenital hypothyroidism potentiates perseveration in a response alternation discrimination task. Neuroscience Research. 36(2). 121–127. 22 indexed citations
9.
Picker, Mitchell J., Richard M. Allen, Drake Morgan, et al.. (1999). Effects of Neuropeptide Y on the Discriminative Stimulus and Antinociceptive Properties of Morphine. Pharmacology Biochemistry and Behavior. 64(1). 161–164. 11 indexed citations
10.
O‘Hare, Eugene, D.T. Weldon, K M Bettin, James Cleary, & John Mach. (1997). Serum Anticholinergic Activity and Behavior Following Atropine Sulfate Administration in the Rat. Pharmacology Biochemistry and Behavior. 56(1). 151–154. 12 indexed citations
11.
Weldon, D.T., Eugene O‘Hare, Michael A. Kuskowski, James Cleary, & John Mach. (1996). Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate. Pharmacology Biochemistry and Behavior. 54(4). 753–757. 13 indexed citations
12.
Cleary, James, et al.. (1995). Beta-amyloid(1–40) effects on behavior and memory. Brain Research. 682(1-2). 69–74. 68 indexed citations
13.
Cleary, James, et al.. (1994). Effects of neuropeptide Y on short-term memory. Brain Research. 653(1-2). 210–214. 25 indexed citations
14.
McDonald, Michael P., et al.. (1994). Effects of an exogenous β-amyloid peptide on retention for spatial learning. Behavioral and Neural Biology. 62(1). 60–67. 68 indexed citations
15.
Rudski, Jeffrey M., David W. Schaal, Travis Thompson, et al.. (1994). Methadone and feeding: Sources of differences between home cage and operant chamber assessment procedures. Pharmacology Biochemistry and Behavior. 49(1). 143–146. 4 indexed citations
16.
Jewett, David C., James Cleary, David W. Schaal, Travis Thompson, & Allen S. Levine. (1993). [Leu31,Pro34]Neuropeptide Y (NPY), but not NPY 20–36, produces discriminative stimulus effects similar to NPY and induces food intake. Brain Research. 631(1). 129–132. 9 indexed citations
17.
Rudski, Jeffrey M., David W. Schaal, Travis Thompson, et al.. (1992). Effects of methadone on free feeding in satiated rats. Pharmacology Biochemistry and Behavior. 43(4). 1033–1037. 12 indexed citations
18.
Jewett, David C., James Cleary, Allen S. Levine, David W. Schaal, & Travis Thompson. (1992). Effects of neuropeptide Y on food-reinforced behavior in satiated rats. Pharmacology Biochemistry and Behavior. 42(2). 207–212. 39 indexed citations
19.
Jewett, David C., David W. Schaal, James Cleary, Travis Thompson, & Allen S. Levine. (1991). The discriminative stimulus effects of neuropeptide Y. Brain Research. 561(1). 165–168. 40 indexed citations
20.
Cleary, James, et al.. (1983). Points : Possible hepatotoxicity of zimelidine. BMJ. 287(6404). 1555.5–1555. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026